Sweet's syndrome in acute myelogenous leukemia presenting as periorbital cellulitis with an infiltrate of leukemic cells

Morgan, Kelli W.; Callen, Jeffrey P.

doi:10.1067/mjd.2001.119032

Cited by 45 publications

(42 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…[7][8][9][10][11][12] There have also been two reports of Sweet syndrome causing orbital cellulitis. 13,14 The pathologic findings of the conjunctiva in patients with Sweet syndrome are similar to the skin findings, with neutrophilic infiltration and oedema in the absence of vasculitis. [9][10][11] Neuro-Sweet disease is a more recently described entity in which encephalitis or meningitis occurs in addition to classic skin findings of Sweet syndrome.…”

Section: Discussionsupporting

confidence: 51%

Neuro-Sweet Disease Causing Orbital Inflammation

Taravati

2015

Neuro-Ophthalmology

View full text Add to dashboard Cite

Section: Discussionsupporting

confidence: 51%

Neuro-Sweet Disease Causing Orbital Inflammation

Taravati

2015

Neuro-Ophthalmology

View full text Add to dashboard Cite

“…66 This is characterised by abrupt onset of fever, neutrophilic leucocytosis, and erythematous, tender pseudovesiculated plaques or nodules that respond readily to corticosteroid therapy. It is usually distinguished by the presence of mature neutrophils on histopathologic examination.…”

mentioning

confidence: 99%

“…In its initial presentation, this syndrome can be confused with orbital cellulitis. 66 Endophthalmitis is also a well-recognised eye manifestation of acute leukaemia with its potentially lethal effects upon visual potential. 67 …”

mentioning

confidence: 99%

Ophthalmic manifestations of acute leukaemias: the ophthalmologist's role

Sharma

Grewal

Gupta

et al. 2004

Eye

209

166

View full text Add to dashboard Cite

With evolving diagnostic and therapeutic advances, the survival of patients with acute leukaemia has considerably improved. This has led to an increase in the variability of ocular presentations in the form of side effects of the treatment and the ways leukaemic relapses are being first identified as an ocular presentation. Leukaemia may involve many ocular tissues either by direct infiltration, haemorrhage, ischaemia, or toxicity due to various chemotherapeutic agents. Ocular involvement may also be seen in graft-versushost reaction in patients undergoing allogeneic bone marrow transplantation, or simply as increased susceptibility to infections as a result of immunosuppression that these patients undergo. This can range from simple bacterial conjunctivitis to an endophthalmitis. Leukaemia can present as pathology in the adnexae, conjunctiva, sclera, cornea, anterior chamber, iris, lens, vitreous, retina, choroid, and optic nerve. Recognition of the varied ocular presentations is also important in assessing the course and prognosis of leukaemia. We have presented a systematic approach taking each part of the eye in turn and outlining how leukaemia has been shown to affect it.

show abstract

“…Синдром ати-пично дебютировал с эритематозной везикуляр-ной сыпи на веках, симулирующей инфекционный периорбитальный целлюлит [74]. Патогистологи-ческое исследование кожи выявило инфильтра-цию зрелыми нейтрофилами и незрелыми мие-лобластными предшественниками.…”

Section: оппортунистические инфекцииunclassified

Ophthalmic manifestation of leukemia

Chistyakova

Викторовна²

2016

Ophthalmology Reports

View full text Add to dashboard Cite

ОфтальмОлОгические ПрОЯвлениЯ леЙкОЗОвG This paper includes a literature review on the ophthalmic manifestations of leukemia. Various eye disorder types in leukemia with concurrent anemia, hypoxia, increased blood viscosity, as well as the compression of tissues by tumor cells conglomerates and/or presence of direct leukemic infiltration were considered. Ophthalmic diseases in patients with hematological malignancies may occur due to opportunistic infections and the impact of such treatments as chemotherapy, radiotherapy and bone marrow transplantation. Reliable estimation of eye involvement rates in leukemic process is difficult, as many patients are asymptomatic at early stages of the disease. However, the predictive value of visual impairment assessment in leukemia is high, which requires close cooperation between ophthalmologists and hematologists, and appropriate adjustment of both local and systemic therapies.G

show abstract

Sweet's syndrome in acute myelogenous leukemia presenting as periorbital cellulitis with an infiltrate of leukemic cells

Cited by 45 publications

References 13 publications

Neuro-Sweet Disease Causing Orbital Inflammation

Neuro-Sweet Disease Causing Orbital Inflammation

Ophthalmic manifestations of acute leukaemias: the ophthalmologist's role

Ophthalmic manifestation of leukemia

Contact Info

Product

Resources

About